Gwenn Hansen is CSO at Nurix Therapeutics, Inc. (NRIX). They have made 20 open-market trades across 1 company since 2021, most recently 2026-10-15.
CIK 0001817160
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 20 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NRIX | 117,227 | $2.9M |
Shares reported on the most recent Form 4, priced at the 2026-10-15 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NRIX | SELL · 10b5-1 | 2026-10-15 | 2026-10-15 | $25.00 | $36K | — | — | — |
| NRIX | SELL · 10b5-1 | 2026-09-01 | 2026-09-01 | $25.47 | $37K | -3.8% | -12.0% | — |
| NRIX | SELL · 10b5-1 | 2026-08-05 | 2026-08-05 | $25.00 | $109K | +7.4% | +3.4% | — |
| NRIX | SELL · 10b5-1 | 2026-08-04 | 2026-08-05 | $24.36 | $100K | +7.4% | +3.4% | — |
| NRIX | SELL | 2026-07-30 | 2026-07-30 | $23.38 | $90K | +10.5% | +9.7% | — |
| NRIX | SELL · 10b5-1 | 2026-06-25 | 2026-06-25 | $20.00 | $108K | +6.5% | +2.5% | +4.6% |
| NRIX | SELL | 2026-04-30 | 2026-04-30 | $16.65 | $53K | -3.8% | +4.8% | +42.2% |
| NRIX | SELL | 2026-01-30 | 2026-01-30 | $16.60 | $81K | -2.5% | -4.3% | +1.1% |
| NRIX | SELL | 2025-10-30 | 2025-10-30 | $12.80 | $105K | +2.0% | +34.1% | +41.7% |
| NRIX | SELL | 2025-07-30 | 2025-07-30 | $12.01 | $103K | -16.5% | -19.1% | +3.0% |
| NRIX | SELL | 2025-04-30 | 2025-04-30 | $11.50 | $39K | -10.8% | -6.8% | +4.2% |
| NRIX | SELL | 2025-01-30 | 2025-01-30 | $19.83 | $140K | -14.6% | -29.2% | -42.5% |
| NRIX | SELL | 2024-10-30 | 2024-10-30 | $24.31 | $167K | +17.2% | -8.0% | -18.6% |
| NRIX | SELL | 2024-07-30 | 2024-07-30 | $20.67 | $141K | -3.7% | +15.6% | +22.3% |
| NRIX | SELL | 2024-04-30 | 2024-04-30 | $12.04 | $24K | +11.8% | +29.0% | +75.9% |
| NRIX | SELL | 2024-01-30 | 2024-01-30 | $7.99 | $19K | +11.0% | +55.0% | +56.5% |
| NRIX | SELL | 2023-10-31 | 2023-11-01 | $5.20 | $8K | -5.6% | +24.1% | +43.4% |
| NRIX | SELL | 2023-07-31 | 2023-08-01 | $9.65 | $18K | -0.5% | -8.6% | -43.4% |
| NRIX | SELL | 2023-05-01 | 2023-05-02 | $9.88 | $11K | +9.4% | +7.6% | +2.8% |
| NRIX | SELL | 2023-01-30 | 2023-02-01 | $11.78 | $17K | -11.8% | -27.4% | -24.7% |
| NRIX | SELL | 2022-10-31 | 2022-11-01 | $12.88 | $15K | +11.3% | -7.1% | -9.5% |
| NRIX | SELL | 2022-08-01 | 2022-08-02 | $15.67 | $19K | -0.7% | -2.7% | -24.5% |
| NRIX | SELL | 2022-05-02 | 2022-05-03 | $11.75 | $13K | -14.2% | -18.5% | +38.1% |
| NRIX | SELL | 2022-01-03 | 2022-01-04 | $28.96 | $106K | -20.0% | -39.3% | -50.1% |
| NRIX | SELL · 10b5-1 | 2021-12-01 | 2021-12-02 | $29.13 | $12K | -3.5% | +4.7% | -46.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.